9/22
12:57 pm
bcda
BioCardia (NASDAQ:BCDA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.
Low
Report
BioCardia (NASDAQ:BCDA) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $25.00 price target on the stock.